Copertina

R software for analysis of recurrent breakpoints in the BRD4 gene

Fuente: Zenodo

Salvato in:

Dettagli Bibliografici
Autore principale:	Wala, Jeremiah
Natura:	Recurso digital
Pubblicazione:	Zenodo 2025
Accesso online:	Acceder al recurso
Tags:	Aggiungi Tag Nessun Tag, puoi essere il primo ad aggiungerne!!

Documenti analoghi

breakpointer2 software for review
di: Destanović, Dalila, et al.
Pubblicazione: (2026)

Estimating breakpoints between climate states in the Cenozoic Era
di: Bennedsen, Mikkel, et al.
Pubblicazione: (2024)

Optimal breakpoint selection method for piecewise linear approximation
di: Liu, Shaojun
Pubblicazione: (2024)

Improved identification of breakpoints in piecewise regression and its applications
di: Kim, Taehyeong, et al.
Pubblicazione: (2024)

Artificial intelligence-generated Arabic subtitles: insights from Veed.io’s automatic speech recognition system of Jordanian Arabic
di: Wala’ Mohammad Akasheh
Pubblicazione: (2024)

Totalitarismustheorien in der jungen BRD
di: Gmehling, Joachim
Pubblicazione: (2022)

BRD4 Signaling Maintains the Differentiated State of β Cells
di: Fuqiang Liu, et al.
Pubblicazione: (2025)

Identification of breakpoint regions and single nucleotide variations of RHD hybrid alleles by long‐read sequencing
di: Ti‐Cheng Chang, et al.
Pubblicazione: (2026)

A BRD4‐Targeting Photothermal Agent for Controlled Protein Degradation
di: Mingwan Shi, et al.
Pubblicazione: (2024)

A BRD4‐Targeting Photothermal Agent for Controlled Protein Degradation
di: Mingwan Shi, et al.
Pubblicazione: (2024)

Primary cutaneous NUT carcinoma with BRD4::NUTM1 fusion
di: Ahmed Shah, et al.
Pubblicazione: (2024)

BRD4 Inhibitor Alleviates Recurrent Spontaneous Abortion via Regulating BRD4 / STAT3 / IL ‐ 17A Axis to Decrease the Th17 Cell Differentiation
di: Fen Liu, et al.
Pubblicazione: (2025)

Efficacy and Safety of Adjuvant Capecitabine in Locoregionally Advanced Nasopharyngeal Carcinoma: A Meta‐Analysis of Phase III Randomized Trials With Subgroup Analysis by Neoadjuvant Chemotherapy
di: Wala Ben Kridis, et al.
Pubblicazione: (2025)

5G Network Security Practices: An Overview and Survey
di: Wala, Fatema Bannat, et al.
Pubblicazione: (2024)

Adjuvant Immune Checkpoint Inhibitors in Head and Neck Cancer: A Meta‐Analysis of Phase III Trials
di: Wala Ben Kridis, et al.
Pubblicazione: (2026)

Understanding the role of BRD8 in human carcinogenesis
di: Kiyoshi Yamaguchi, et al.
Pubblicazione: (2024)

Rational Design of CDK12/13 and BRD4 Molecular Glue Degraders
di: Zhe Zhuang, et al.
Pubblicazione: (2025)

Rational Design of CDK12/13 and BRD4 Molecular Glue Degraders
di: Zhe Zhuang, et al.
Pubblicazione: (2025)

Exploring the Impact of miR‐34b‐5p on BRD4 Gene Expression in Triple‐Negative Breast Cancer Cells
di: Mohannad Abdulameer Ibrahim, et al.
Pubblicazione: (2025)

Identification of potent BRD4‐BD1 inhibitors using classical and steered molecular dynamics based free energy analysis
di: Ashish Gupta, et al.
Pubblicazione: (2024)

Synthesis and Application of BRD4‐Targeting ByeTACs (Bypassing E‐Ligase Targeting Chimeras)
di: Cody A. Loy, et al.
Pubblicazione: (2025)

Co-condensation and multivalency enable acetylation-sensitive, concentration-robust assembly of BRD4 condensates
di: Polyachenko, Yury, et al.
Pubblicazione: (2026)

Study on the Binding Selectivity of Three Pyridinone Analogs With BRD4 Using Multiple Molecular Dynamics Simulations
di: Rui‐Ge Wang, et al.
Pubblicazione: (2026)

Discovery of an orally bioavailable pyridone-based BRD4 inhibitor with potent antitumor efficacy in colorectal cancer.
di: Fang, Zhangyun, et al.
Pubblicazione: (2026)

BreakBRD Galaxies: Evolutionary Clues Through an Analysis of Gas Content
di: Stark, David V., et al.
Pubblicazione: (2024)

BRD8 Guards the Pluripotent State by Sensing and Maintaining Histone Acetylation
di: Li Sun, et al.
Pubblicazione: (2024)

Cocaine‐Induced Changes in the BRD 4 Interactome Identifies Casein Kinase 1 Epsilon as a Therapeutic Target
di: Afshin Seyednejad, et al.
Pubblicazione: (2026)

Hidden danger: maize starch excipient allergy
di: Wala Hamid Haj Ali, et al.
Pubblicazione: (2024)

Systematic Management of a Critical CYP3A4 Interaction Between Cabozantinib and Carbamazepine: A Case Report of a Clinically Relevant Pharmacokinetic Interaction
di: Pierre Nizet, et al.
Pubblicazione: (2026)

UCBShift 2.0 Chemical Shift Predictions for ET-BRD3 / TP
di: Benavides, Tiburon
Pubblicazione: (2025)

BRD9 inhibition as potential treatment option for testicular germ cell tumors
di: Aylin Hansen, et al.
Pubblicazione: (2025)

Tumor suppressive role of the epigenetic master regulator BRD3 in colorectal cancer
di: Masahiro Hashimoto, et al.
Pubblicazione: (2024)

The Age of the R127 & R128 Clusters: Implications for the LBV
di: Aghakhanloo, Mojgan, et al.
Pubblicazione: (2026)

BRD4-mediated transcriptional activation of PDLIM4 enhances p21 stability and chemosensitivity in lung adenocarcinoma independent of p53.
di: Wang, Qingwei, et al.
Pubblicazione: (2026)

PRMT1 ‐mediated BRD4 arginine methylation and phosphorylation promote partial epithelial–mesenchymal transformation and renal fibrosis
di: Chongxiang Xiong, et al.
Pubblicazione: (2025)

A Ruthenium(II) Complex Inhibits BRD4 for Synergistic Seno‐ and Chemo‐Immunotherapy in Cisplatin‐Resistant Tumor Cells
di: Jinrong Yang, et al.
Pubblicazione: (2025)

Identification of BRD4 (BD1) Selective Inhibitors Based on Machine Learning, Molecular Docking and Molecular Dynamics Simulation
di: Zhao‐Tong Jia, et al.
Pubblicazione: (2025)

Pi*S and Pi*Z Alleles of SERPINA1 Gene Are Associated With Specific Variants of a BRD4‐Independent Enhancer
di: Ainhoa Escuela-Escobar, et al.
Pubblicazione: (2024)

consexpressionR: an R package for consensus differential gene expression analysis
di: Costa-Silva, Juliana, et al.
Pubblicazione: (2025)

Quantitative research in entrepreneurship using R software for data analysis
di: Daniel do Prado Pagotto
Pubblicazione: (2023)